mTOR Inhibitor Immunosuppressant class drugs

4 results

  • everolimus

    (Everolimus)
    ENDO USA, Inc.
    Everolimus Tablets are indicated for postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer; adults with progressive neuroendocrine tumors (pancreatic, gastrointestinal, or lung origin); advanced renal cell carcinoma after prior treatment failure; renal angiomyolipoma associated with tuberous sclerosis complex; and subependymal giant cell astrocytoma in TSC patients.
    Medication Details
    Drug Interactions

  • everolimus

    (Everolimus)
    Ascend Laboratories, LLC
    Everolimus tablets are indicated for the prophylaxis of organ rejection in adult kidney transplant patients at low to moderate immunologic risk, in conjunction with basiliximab, cyclosporine, and corticosteroids. They are also used for liver transplant patients starting no sooner than 30 days post-transplant, alongside tacrolimus and corticosteroids.
    Medication Details
    Drug Interactions

  • sirolimus

    (sirolimus)
    Glenmark Pharmaceuticals Inc., USA
    Sirolimus tablets are indicated for the prophylaxis of organ rejection in renal transplant patients aged 13 and older and for treating lymphangioleiomyomatosis (LAM). In renal transplantation, it is used in combination with cyclosporine and corticosteroids, especially for patients at high immunologic risk.
    Medication Details
    Drug Interactions

  • sirolimus

    (Sirolimus)
    VistaPharm, LLC
    Sirolimus Oral Solution is indicated for the prophylaxis of organ rejection in renal transplant patients aged 13 and older. It is used with cyclosporine and corticosteroids, particularly in patients at low-to-moderate immunologic risk, with specific combinations recommended for high-immunologic risk patients.
    Medication Details
    Drug Interactions